Biological TherapyBiological ProductsRadiation InjuriesRadiation DosageRadiation, IonizingAntirheumatic AgentsDose-Response Relationship, RadiationRadiation ToleranceAntineoplastic AgentsRadiotherapyRadiotherapy DosageRadiationArthritis, RheumatoidCombined Modality TherapyRadiation ProtectionRadiation OncologyAntibodies, MonoclonalTreatment OutcomeRadiotherapy, ConformalRadiation MonitoringNeoplasmsRadiotherapy, Intensity-ModulatedPsoriasisPhenetidineAntibodies, Monoclonal, HumanizedArthritis, PsoriaticImmunologic FactorsDose FractionationDermatologic AgentsRadiotherapy Planning, Computer-AssistedRadiotherapy, AdjuvantRadiation PneumonitisBrachytherapySpondylarthritisCell Line, TumorRadiometryReceptors, Tumor Necrosis FactorRadiation-Sensitizing AgentsNeoplasms, Radiation-InducedClinical Trials as TopicRadiation Injuries, ExperimentalAntibodies, Monoclonal, Murine-DerivedRheumatic DiseasesRadiosurgeryTumor Necrosis Factor-alphaGamma RaysTime FactorsDrug Screening Assays, AntitumorCosmic RadiationOff-Label UseRetrospective StudiesSchizophrenia, CatatonicAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy, Computer-AssistedBrain NeoplasmsAnti-Inflammatory AgentsCisplatinDoxorubicinGastrointestinal AgentsCranial IrradiationApoptosisImmunotherapyParticle AcceleratorsNeoplasm Recurrence, LocalRadiotherapy, Image-GuidedInflammatory Bowel DiseasesCrohn DiseaseCell SurvivalRadiation-Protective AgentsHead and Neck NeoplasmsBackground RadiationRadiodermatitisBreast NeoplasmsImmunoglobulin GMethotrexateImmunosuppressive AgentsPrognosisRadiotherapy, High-EnergyImmunoconjugatesUltraviolet RaysNeoplasm StagingModels, BiologicalOrgans at RiskDNA DamageProstatic NeoplasmsCobalt RadioisotopesDrug Resistance, NeoplasmAntineoplastic Agents, PhytogenicCarcinoma, Squamous CellRadiation EffectsChemoradiotherapyRadiobiologySurvival AnalysisAdenocarcinomaTumor Cells, CulturedMice, NudeDisease ProgressionXenograft Model Antitumor AssaysGenetic TherapyAntibiotics, Antineoplastic